Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Chemed Corporation (CHE:NYSE), powered by AI.
Chemed Corporation is currently trading at $419.31. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Chemed Corporation on Alpha Lenz.
Chemed Corporation's P/E ratio is 22.8.
“Chemed Corporation trades at a P/E of 22.8 (fair value) with strong ROE of 25.3%.”
Ask for details →Chemed Corporation operates as a diversified healthcare services provider, primarily serving the niches of hospice care and plumbing services across the United States. Its primary function is divided into two main segments: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, as one of the nation's largest hospice care providers, delivers end-of-life care through a network of physicians, nurses, and home health aides, significantly impacting the healthcare sector by meeting the needs of terminally ill patients and their families. Meanwhile, Roto-Rooter offers plumbing and drain cleaning services, marking its influence in the maintenance and improvement sector of residential and commercial properties. Chemed's business model highlights the importance of balancing core service offerings in healthcare and essential residential services, offering resilience and stability in diverse economic conditions. The company's ability to operate in these distinct sectors showcases its strategic diversification, thereby playing a vital role in both healthcare and service industries, reinforcing its significance in the market as a versatile entity capable of sustaining growth through essential, albeit varied, service provisions.
“Chemed Corporation trades at a P/E of 22.8 (fair value) with strong ROE of 25.3%.”
Ask for details →Chemed Corporation (ticker: CHE) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 15,695 employees. Market cap is $6.0B.
The current price is $419.31 with a P/E ratio of 22.76x and P/B of 6.16x.
ROE is 25.28% and operating margin is 13.48%. Annual revenue is $2.5B.